Risks from Surging Raw Material Prices and Procurement Difficulties
First written in FY2017. 5 of 12 entries say "Restated". Latest entry: 2026-08-06.
Fuji Pharma moved to the "Worse" side of this theme in 2023, 2 years after the typical company in this theme (2021).
The whole theme swung hardest in 2022: 122 of 167 companies on the "Worse" side.
50 other companies' latest entry also says "Restated".
- 2026-08-06RestatedEarnings
「The trend toward yen depreciation continued amid soaring raw material and energy prices.」
The company continues to describe the external environment of high raw material and energy prices and continued yen depreciation. - FY2024-Q2RestatedAnnual report
「During the second quarter of the fiscal year under review, Japan's economy continued to face unstable global conditions, soaring raw material and energy prices, and a weakening trend in the yen.」
The Company continues to disclose the external environment of soaring raw-material and energy prices and the ongoing trend toward yen depreciation as pressure on raw-material costs and procurement conditions. - FY2024-Q1MaterialisedAnnual report
「The Company incorporated the sales loss on biologically derived products resulting from higher active pharmaceutical ingredient prices into its full-year sales plan, and the recognition of this loss in full as an inventory write-down in the first quarter caused first-quarter gross profit to fall significantly below the year-earlier level.」
The Company states that higher active pharmaceutical ingredient prices appeared in actual quarterly results as sales losses on biologically derived products and inventory write-downs. - FY2023-Q3RestatedAnnual report
「During the third quarter of the fiscal year under review, Japan's economy began to show signs of recovery, particularly in private consumption, as efforts to balance COVID-19 measures with economic activity progressed. However, amid continuing instability in global conditions, soaring raw material and energy prices, and sharp exchange-rate fluctuations, prices continued to rise, leaving the outlook uncertain.」
The Company continues to state, following the previous quarter, that raw-material and energy prices are soaring and prices in general continue to rise, indicating ongoing pressure on costs and procurement conditions. - FY2023-Q2WorsenedAnnual report
「During the second quarter of the fiscal year under review, Japan's economy began to show signs of recovery, particularly in private consumption, as efforts to balance COVID-19 measures with economic activity progressed. However, amid continuing instability in global conditions, soaring raw material and energy prices, and sharp exchange-rate fluctuations, prices continued to rise, leaving the outlook uncertain.」
The Company continues to state that raw-material and energy prices are soaring and prices in general continue to rise, indicating pressure on the cost environment. - FY2023-Q1WorsenedAnnual report
「During the first quarter of the fiscal year under review, Japan's economy began to show signs of recovery, particularly in private consumption, as efforts to balance COVID-19 measures with economic activity progressed. However, amid continuing instability in global conditions, soaring raw material and energy prices, and sharp exchange-rate fluctuations, prices continued to rise, leaving the outlook uncertain.」
Raw-material and energy prices are described as soaring this time, compared with the increases reported in the previous fiscal year, while prices in general are stated to continue rising, indicating growing pressure on costs and procurement conditions. - FY2022RestatedAnnual report
「The Group procures raw materials in Japan and overseas and is progressively diversifying the supply chain for raw materials used in important products. However, soaring raw-material prices may affect product costs, while fluctuations in the supply-demand balance for raw materials, domestic and overseas regulations, or quality problems at raw-material manufacturers may make raw materials difficult to obtain over an extended period, preventing the manufacture and sale of products and affecting the Group's business performance.」
The Company continues to disclose procurement risks arising from raw-material prices, supply and demand, regulations and quality problems, as well as the diversification of the supply chain for important raw materials. - FY2022-Q3RestatedAnnual report
「Following Russia's invasion of Ukraine and other factors, raw-material and energy prices have risen and prices in general have begun to increase, creating an uncertain and unpredictable outlook both in Japan and overseas.」
Pressure on costs and procurement conditions from higher raw-material and energy prices is stated, as in the previous quarter. - FY2022-Q2WorsenedAnnual report
「Following Russia's invasion of Ukraine and other factors, raw-material and energy prices have risen and prices in general have begun to increase, creating an uncertain and unpredictable outlook both in Japan and overseas.」
The rise in raw-material prices is stated as an actual change in the external environment, with growing pressure on raw-material costs and procurement conditions. - FY2021MitigatedAnnual report
「The Company is progressively diversifying the supply chain for raw materials used in important products. However, soaring raw-material prices may affect product costs, while fluctuations in the supply-demand balance for raw materials, domestic and overseas regulations, or quality problems at raw-material manufacturers may make raw materials difficult to obtain over an extended period, preventing the manufacture and sale of products and affecting the Group's business performance.」
The Company continues to disclose raw-material procurement risks while progressively diversifying the supply chain for important raw materials. - FY2020MaterialisedAnnual report
「During the current fiscal year, demand increased worldwide for certain raw materials used in the Company's products that are said to be used in the treatment of COVID-19, and there were instances in which they temporarily became difficult to obtain. As a measure, the Company established an internal Stable Supply Committee, conducts regular checks on raw-material procurement, and has established a framework for taking company-wide measures promptly when risks arise. In addition, it is progressively diversifying the supply chain for raw materials used in important products.」
The Company states that demand growth for raw materials related to COVID-19 actually caused temporary procurement difficulties. It also identifies the establishment of the Stable Supply Committee and diversification of suppliers as measures. - FY2017First statedAnnual report
「Increases in the prices of raw materials and other items may affect product costs. In addition, domestic and overseas regulations relating to raw materials or quality problems at raw-material manufacturers may make raw materials difficult to obtain over an extended period, preventing the manufacture and sale of products and affecting the Group's business performance.」
The impact on procurement, manufacturing and sales of raw-material prices, regulations and quality problems at suppliers is stated.